Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02864953
Brief Title: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction (CHARM)

First Submitted : July 12, 2016
First Submitted that Met QC Criteria : August 9, 2016
First Posted : August 12, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 25, 2021
Last Update Posted : August 26, 2021